SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Kardashian-backed CBD brand to launch in Europe

    By
    Home / Kardashian-backed CBD brand to launch in Europe

    One of the USA’s largest CBD brands, Ambrani, will be expanding its distribution to see its products – which have been backed by Kim Kardashian – reach customers in Europe.

    The company has announced that its CBD products will now be carried in Europe’s largest retailer, El Corte Ingles, and will continue its expansion into Germany, France, Portugal and Nordic Countries.

    It will also focus on Germany for retailer brick-and-mortar retail locations in anticipation of cannabis legalisation in 2023.

    Read more: Flora Growth confirms direct distribution lines to Europe

    With Germany plans to legalise Cannabis, the company has stated it is is perfectly positioned to be one Europe’s leading cannabis and CBD manufacturers. Once Germany legalises Cannabis, many other European countries will follow Germany’s path to legalisation and Ambari Brands will perfectly positioned with retail and online penetration all over Europe.

    Ambari Brands shares are available for purchase In Germany and are also listed in Canada. Its shares are publicly traded and have attracted much attention since its IPO.

    With Europe’s energy crisis, Ambari Brands is the first cannabis company that is aiming to manufacture its products in manufacturing facilities powered by clean energy. 

    Its initial goal is to produce in industrial hubs that are powered by wind and sola, and the company’s final goal is to produce its European products in Hamburg’s green hydrogen hub which is set to be built in the next few years.

    The brand is currently carried in Americas largest retailers, such as Saks Fifth Avenue, Neiman Marcus, Bergdorf Goodman and many more, and is also backed by Kim Kardashian, one of the world’s largest celebrities.

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.